⚠ BETA — all market data shown (deals, filings, prices, indices) is demo / illustrative, not live trading data. For evaluation only; verify before acting.
June 16, 2026
The Dispatch

NSE

Marksans Pharma LimitedMARKSANS

Marksans Pharma Limited is an NSE-listed company (MARKSANS).

AI-generated overview — verify before relying on it.

Net institutional flow

+₹371.1 Cr

Institutional buyers

8 in / 0 out

High-impact filings

0 · tilt Bullish

Next corporate action

Dividend - Re 0.80 Per Share

ex 2025-08-01

Competitive landscape — the read

vs most-traded names
Institutional money is backing MARKSANS hardest (+₹371.1 Cr net). MARKSANS leads this set on institutional accumulation. Filing momentum favours MARKSANS (+1).
#CompanyInst. flow ₹CrDealsHi-impactFiling mom.BuzzNews
1MARKSANSThis+₹371.1 Cr18—+1——
2MTNL+₹41.3 Cr331————
3ATALREAL+₹7.4 Cr363————
4GATECH+₹0.4 Cr298————
5IRMENERGY−₹2.2 Cr356————
6QUADFUTURE−₹9 Cr571————
7MOBIKWIK−₹150.9 Cr975————

Ranked by net institutional flow (buys − sells, ₹Cr). Filing momentum = bullish − bearish filings; Buzz = news+social sentiment. Curate peers in the company admin.

Timeline — MARKSANS day by day

  1. 2026-06-16FilingMarksans Pharma Limited has informed the Exchange about Update on acquisition of QliniQ B.V.M&A
  2. 2026-06-09FilingMarksans Pharma Limited has informed the Exchange that India Ratings and Research has revised the outlook forRating
  3. 2026-06-08FilingMarksans Pharma Limited has informed the Exchange about Schedule for Virtual Investor ConferenceInvestor Call
  4. 2025-08-01ActionDividend - Re 0.80 Per ShareDividend
  5. 2025-06-11BulkSELL · ₹256.8 CrORBIMED ASIA IV MAURITIUS FVCI LIMITED
  6. 2025-06-11BulkBUY · ₹75 CrUNIFI BLEND FUND 2
  7. 2025-06-11BulkBUY · ₹81.2 CrUNIFI CAPITAL PRIVATE LIMITED -BLENDED RANGOLI
  8. 2025-06-11BlockBUY · ₹15 CrBANDHAN MUTUAL FUND
  9. 2025-06-11BlockBUY · ₹10 CrCITIGROUP GLOBAL MARKETS SINGAPORE PTE LIMITED
  10. 2025-06-11BlockSELL · ₹256.8 CrORBIMED ASIA IV MAURITIUS FVCI LIMITED
  11. 2025-06-11BlockBUY · ₹23 CrSOCIETE GENERALE
  12. 2025-06-11BlockBUY · ₹13.4 CrSUBHKAM VENTURES I PRIVATE LIMITED
  13. 2025-06-11BlockBUY · ₹14 CrUNIFI BCAD FUND
  14. 2025-06-11BlockBUY · ₹75 CrUNIFI BLEND FUND 2
  15. 2025-06-11BlockBUY · ₹14.8 CrUNIFI CAPITAL PRIVATE LIMITED
  16. 2025-06-11BlockBUY · ₹81.2 CrUNIFI CAPITAL PRIVATE LIMITED -BLENDED RANGOLI
  17. 2025-06-11BlockBUY · ₹10.4 CrUTI MUTUAL FUND
  18. 2024-09-20BulkSELL · ₹74.8 CrGRAVITON RESEARCH CAPITAL LLP
  19. 2024-09-20BulkBUY · ₹74.8 CrGRAVITON RESEARCH CAPITAL LLP
  20. 2024-09-20BulkSELL · ₹107.9 CrUBS PRINCIPAL CAPITAL ASIA LIMITED
  21. 2024-09-20BulkBUY · ₹72.9 CrVANGUARD EMERGING MARKETS STOCK INDEX FUND A SERIES OF VANGUARD INTERNATIONAL EQUITY INDEX FUNDS
  22. 2024-09-20BulkBUY · ₹85.5 CrVANGUARD TOTAL INTERNATIONAL STOCK INDEX FUND
  23. 2024-09-17ActionDividend - Rs 0.60 Per ShareDividend

Merged from deals, filings, corporate actions and news — newest first. Scope the deal/action portion with the period chips below.

Filings that matter

  • 5
    M&ABullish

    Update on acquisition of QliniQ B.V.

    Source PDF →
  • 2
    RatingNeutral

    India Ratings and Research has revised the outlook for the Company s bank loan facilities to Positive from Stable

    Source PDF →
  • 2
    Investor CallNeutral

    Schedule for Virtual Investor Conference

    Source PDF →

Bulk & block deals

1M3M6M1Y2YAll

18 deals · 2024-09-20 → 2025-06-11

DateCounterpartyInvestor typeSideValue
2025-06-11ORBIMED ASIA IV MAURITIUS FVCI LIMITEDHNI / otherSELL₹256.8 Cr
2025-06-11UNIFI BLEND FUND 2InstitutionBUY₹75 Cr
2025-06-11UNIFI CAPITAL PRIVATE LIMITED -BLENDED RANGOLIHNI / otherBUY₹81.2 Cr
2025-06-11BANDHAN MUTUAL FUNDInstitutionBUY₹15 Cr
2025-06-11CITIGROUP GLOBAL MARKETS SINGAPORE PTE LIMITEDInstitutionBUY₹10 Cr
2025-06-11ORBIMED ASIA IV MAURITIUS FVCI LIMITEDHNI / otherSELL₹256.8 Cr
2025-06-11SOCIETE GENERALEHNI / otherBUY₹23 Cr
2025-06-11SUBHKAM VENTURES I PRIVATE LIMITEDInstitutionBUY₹13.4 Cr
2025-06-11UNIFI BCAD FUNDInstitutionBUY₹14 Cr
2025-06-11UNIFI BLEND FUND 2InstitutionBUY₹75 Cr

18 deals in the selected window — corporate actions are scoped to the same period. ~2 years of history available.

Results & transcripts

Financial results

None yet.

News & chatter on MARKSANS

RSS News

0

No recent news.

Google News RSS — links open the source.

The Dispatch

0

No articles yet.

Our coverage.

Reddit

0

No Reddit chatter.

r/ posts mentioning the company.

Twitter / X

0

No posts.

Posts mentioning the company.